These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer]. Thomas M, Rübe C, Semik M, Junker K, von Eiff M. Dtsch Med Wochenschr; 1997 Aug 15; 122(33):993-8. PubMed ID: 9296933 [Abstract] [Full Text] [Related]
3. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR. J Thorac Cardiovasc Surg; 2004 Jan 15; 127(1):108-13. PubMed ID: 14752420 [Abstract] [Full Text] [Related]
4. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M. Ann Thorac Surg; 2004 Oct 15; 78(4):1200-5; discussion 1206. PubMed ID: 15464470 [Abstract] [Full Text] [Related]
5. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer. Ajlouni M, Chapman R, Kim JH. Cancer J Sci Am; 1996 Oct 15; 2(6):314-20. PubMed ID: 9166551 [Abstract] [Full Text] [Related]
6. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma. Nguyen NP, Leonardo JM, Karlsson U, Vos P, Bullock L, Thomas P, Lepera P, Ludin A, Chu C, Salehpour M, Jendrasiak G, Sallah S. Anticancer Res; 2002 Oct 15; 22(6B):3429-35. PubMed ID: 12552935 [Abstract] [Full Text] [Related]
9. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W. Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129 [Abstract] [Full Text] [Related]
13. [Neoadjuvant chemotherapy and chemoradiotherapy in locally advanced stage IIIA and IIIB of non-small-cell bronchial carcinoma (the Essen concept)]. Eberhardt W. Praxis (Bern 1994); 1997 Oct 15; 86(42):1647-53. PubMed ID: 9432686 [Abstract] [Full Text] [Related]
14. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. Häberle B, Bode U, von Schweinitz D. Klin Padiatr; 2003 Oct 15; 215(3):159-65. PubMed ID: 12778356 [Abstract] [Full Text] [Related]
15. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M. Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1106-12. PubMed ID: 15519781 [Abstract] [Full Text] [Related]
16. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer. Rojas AM, Lyn BE, Wilson EM, Williams FJ, Shah N, Dickson J, Saunders MI. Cancer; 2006 Sep 15; 107(6):1321-30. PubMed ID: 16902985 [Abstract] [Full Text] [Related]